Literature DB >> 17679767

Effectiveness of (99m)Tc-tetrofosmin for assessment of heart functions in micropigs.

Min Young Lee1, Sang Hun Lee, Jae Hong Park, Jung Sun Heo, Yu Jin Lee, Han Na Suh, Jung Jun Min, Young Soon Seo, Ho Jae Han.   

Abstract

This study examined the suitability of a nuclear imaging technique using (99m)Tc-tetrofosmin as an agent to assess the heart functions of healthy micropigs. The mean age of the pigs was 360 days (male), and the mean body weight was 35.3 kg ranging from 34.5-36 kg. There were no significant perfusion defects in any of the reconstructed images. Gated single-photon emission computed tomography imaging can be used to calculate the ventricular volume and ejection fraction (EF). In this case, an EF of 79% was calculated from the ventricular volume of the end-systolic image (10 ml) subtracted from that of the end-diastolic volume (49 ml). A perfusion defect (particularly the apex, lateral wall) is unlikely because of the presence of a preserved wall motion in a segment with a defect. It is concluded that quantitative cardiac scintigraphy, using (99m)Tc-tetrofosmin is an adequate technique for estimating the heart functions of healthy micropigs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679767      PMCID: PMC2868127          DOI: 10.4142/jvs.2007.8.3.223

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  18 in total

1.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).

Authors:  Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin G St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  Circulation       Date:  2003-09-16       Impact factor: 29.690

Review 2.  34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective?

Authors:  Daniel B Mark; Leslee J Shaw; Michael S Lauer; Patrick G O'Malley; Paul Heidenreich
Journal:  J Am Coll Cardiol       Date:  2003-06-04       Impact factor: 24.094

3.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

4.  The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States.

Authors:  R W Evans; C E Orians; N L Ascher
Journal:  JAMA       Date:  1992-01-08       Impact factor: 56.272

5.  Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness.

Authors:  Rory Hachamovitch; Daniel S Berman; Hosen Kiat; Ishac Cohen; John D Friedman; Leslee J Shaw
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

6.  Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.

Authors:  G Münch; J Neverve; I Matsunari; G Schröter; M Schwaiger
Journal:  J Nucl Med       Date:  1997-03       Impact factor: 10.057

7.  Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.

Authors:  P Flamen; A Bossuyt; P R Franken
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

8.  Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact.

Authors:  E G DePuey; A Rozanski
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

Review 9.  The efficacy of cardiovascular nuclear medicine exercise studies.

Authors:  A Rozanski; D S Berman
Journal:  Semin Nucl Med       Date:  1987-04       Impact factor: 4.446

10.  Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.

Authors:  R Hachamovitch; D S Berman; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.